stars 1 stars 2 stars 3

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist and preclinical GIPR modulator programs. For more information, please visit: www.ternspharma.com.

Terns Pharmaceuticals Questions

The Terns Pharmaceuticals annual revenue was $13.9 million in 2026.

Robin Andrulevich is the Chief People Officer (Part Time) of Terns Pharmaceuticals.

52 people are employed at Terns Pharmaceuticals.

Terns Pharmaceuticals is based in Foster City, California.

The NAICS codes for Terns Pharmaceuticals are [325, 32541, 32, 541, 3254, 54].

The SIC codes for Terns Pharmaceuticals are [28, 283].

Top Terns Pharmaceuticals Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users